238 related articles for article (PubMed ID: 11787348)
1. [Evaluation of follow-up and evolution of multiple sclerosis].
Couvreur G
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
[TBL] [Abstract][Full Text] [Related]
2. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
Ozakbas S; Cagiran I; Ormeci B; Idiman E
J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
[TBL] [Abstract][Full Text] [Related]
3. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
Ozakbas S; Ormeci B; Idiman E
J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
[TBL] [Abstract][Full Text] [Related]
4. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Gladstone DE; Zamkoff KW; Krupp L; Peyster R; Sibony P; Christodoulou C; Locher E; Coyle PK
Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
[TBL] [Abstract][Full Text] [Related]
5. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
[TBL] [Abstract][Full Text] [Related]
6. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
7. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
[TBL] [Abstract][Full Text] [Related]
8. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
[TBL] [Abstract][Full Text] [Related]
9. [Value of MRI in patients with multiple sclerosis].
Tourbah A
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1124-7. PubMed ID: 11787344
[TBL] [Abstract][Full Text] [Related]
10. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
11. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
Minneboo A; Barkhof F; Polman CH; Uitdehaag BM; Knol DL; Castelijns JA
Arch Neurol; 2004 Feb; 61(2):217-21. PubMed ID: 14967769
[TBL] [Abstract][Full Text] [Related]
12. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
14. Assessing disability progression with the Multiple Sclerosis Functional Composite.
Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
[TBL] [Abstract][Full Text] [Related]
15. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
[TBL] [Abstract][Full Text] [Related]
16. A randomized crossover study of bee sting therapy for multiple sclerosis.
Wesselius T; Heersema DJ; Mostert JP; Heerings M; Admiraal-Behloul F; Talebian A; van Buchem MA; De Keyser J
Neurology; 2005 Dec; 65(11):1764-8. PubMed ID: 16221950
[TBL] [Abstract][Full Text] [Related]
17. Validity of performance scales for disability assessment in multiple sclerosis.
Marrie RA; Goldman M
Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
Mathiesen HK; Langkilde AR; Larsson HB
Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
[TBL] [Abstract][Full Text] [Related]
20. Defining interferon beta response status in multiple sclerosis patients.
Rudick RA; Lee JC; Simon J; Ransohoff RM; Fisher E
Ann Neurol; 2004 Oct; 56(4):548-55. PubMed ID: 15389896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]